Search Results - "Rodríguez Portal, J.A."

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial by Flaherty, Kevin R, Brown, Kevin K, Inoue, Yoshikazu, Moua, Teng, Crestani, Bruno, Wuyts, Wim A, Stowasser, Susanne, Quaresma, Manuel, Goeldner, Rainer-Georg, Schlenker-Herceg, Rozsa, Kolb, Martin, Aburto, M., Acosta, O., Antin-Ozerkis, D., Arce, G., Barczyk, A., Bascom, R., Bazdyrev, E., Belloli, E., Bergna, M.A., Blaas, S., Bondue, B., Bonella, F., Cantin, A., Castillo Villegas, D.M., Cazaux, A., Cerri, S., Cottin, V., Crestani, B., Dahlqvist, C., Danoff, S., Dematte D'Amico, J., Dilling, D., Elias, P., Falk, J., Fernández Pérez, E.R., Gamez-Dubuis, A., Giessel, G., Glassberg, M., Glazer, C., Guiot, J., Hirani, N., Homik, L., Hope-Gill, B., Hotchkin, D., Ilkovich, M., Inoue, Y., Jassem, E., Jones, L., Kitamura, H., Kolb, M., Kono, C., Kulkarni, T., León Jiménez, A., Luo, Q., Mageto, Y., Maher, T.M., Makino, S., Martinez, R., Martínez, M., Miyazaki, Y., Morrison, L., Morrow, L., Moua, T., Nambiar, A., Nunes, H., Okamoto, M., Otaola, M., Park, J.S., Patel, N., Pesci, A., Poonyagariyagorn, H., Quadrelli, S., Randerath, W., Reynaud-Gaubert, M., Rosas, I., Safdar, Z., Saito, T., Sakamoto, N., Schmidt, S., Scholand, M.B., Shapera, S., Shlobin, O., Sigal, B., Silva Orellana, A., Song, J.W., Stone, H., Sugiura, H., Takaya, H., Takeuchi, T., Thavarajah, K., Tolle, L., Tomii, K., Valenzuela, C., Vancheri, C., Varone, F., Veeraraghavan, S., Wemeau, L., Yakusevich, V., Yamada, Y.

“…The INBUILD trial investigated the efficacy and safety of nintedanib versus placebo in patients with progressive fibrosing interstitial lung diseases (ILDs)…”
Get full text

Smoking-related interstitial lung disease by Serrano Gotarredona, M.P., Navarro Herrero, S., Gómez Izquierdo, L., Rodríguez Portal, J.A.

“…Exposure to smoke is associated with the development of diseases of the airways and lung parenchyma. Apart from chronic obstructive pulmonary disease (COPD),…”
Get full text